U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.2804C>T (p.Thr935Met) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 19, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000780917.1

Allele description [Variation Report for NM_000051.4(ATM):c.2804C>T (p.Thr935Met)]

NM_000051.4(ATM):c.2804C>T (p.Thr935Met)

Gene:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.2804C>T (p.Thr935Met)
Other names:
p.T935M:ACG>ATG
HGVS:
  • NC_000011.10:g.108268575C>T
  • NG_009830.1:g.50744C>T
  • NM_000051.4:c.2804C>TMANE SELECT
  • NM_001351834.2:c.2804C>T
  • NP_000042.3:p.Thr935Met
  • NP_000042.3:p.Thr935Met
  • NP_001338763.1:p.Thr935Met
  • LRG_135t1:c.2804C>T
  • LRG_135:g.50744C>T
  • LRG_135p1:p.Thr935Met
  • NC_000011.9:g.108139302C>T
  • NM_000051.3:c.2804C>T
  • Q13315:p.Thr935Met
  • p.T935M
Protein change:
T935M
Links:
UniProtKB: Q13315#VAR_056682; dbSNP: rs3218708
NCBI 1000 Genomes Browser:
rs3218708
Molecular consequence:
  • NM_000051.4:c.2804C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351834.2:c.2804C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000918568Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Oct 19, 2018)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks.

Decker B, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Ahmed S, Baynes C, Conroy DM, Brown J, Luben R, Ostrander EA, Pharoah PD, Dunning AM, Easton DF.

J Med Genet. 2017 Nov;54(11):732-741. doi: 10.1136/jmedgenet-2017-104588. Epub 2017 Aug 4.

PubMed [citation]
PMID:
28779002
PMCID:
PMC5740532

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.

Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D; Breast Cancer Susceptibility Collaboration (UK)., Easton DF, Stratton MR, Rahman N.

Nat Genet. 2006 Aug;38(8):873-5. Epub 2006 Jul 9.

PubMed [citation]
PMID:
16832357
See all PubMed Citations (6)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000918568.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Variant summary: ATM c.2804C>T (p.Thr935Met) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 282986 control chromosomes, predominantly at a frequency of 0.0001 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than expected for a pathogenic variant in ATM causing Breast Cancer (6.4e-05 vs 0.001), allowing no conclusion about variant significance. The variant, c.2804C>T, has been reported in the literature in individuals affected with colorectal cancer (Yurgelun_2015, Yurgelun_JAMAOnc_2016) but also in controls (Tavtigian_2009, Renwick_2006). These reports do not provide unequivocal conclusions about association of the variant with breast cancer. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS x3, likely benign x1). Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024